2019 (v1)
Publication
No description
Uploaded on: April 14, 2023
A
E
Last name: ANGELUCCI
First name: E
No description
No description
Background and purpose The best therapeutic approach for aggressive relapsing-remitting multiple sclerosis remains unknown. The objective was to compare the efficacy and safety of autologous haematopoietic stem cell transplantation (aHSCT) and alemtuzumab in aggressive relapsing-remitting multiple sclerosis. Methods The time to first relapse,...
No description